Download my CV here







Professor Andrew Scholey
Monash and Swinburne Universities 
Melbourne

Australia
Email: andrew@scholeylab.com (or click icon top right)














About Research Publications Funding Talks
Misc.
Other Home
About Scholey Scholey's funding Scholey's talks Scholey home
About Scholey

Funding...

[Andrew has been awarded over $25 million in research funding from government grant schemes and industry]
          Specific grants (as Principal Investigator unless marked*)
  • Boosting immune responses and cognitive support with Neuroberry® blackcurrant (2021-2022)
    High-Value Nutrition Contestable Fund (New Zealand)*

  • Unlocking the potential of polyphenols: A novel approach to target the gut-brain axis (2022-2023)
    High-Value Nutrition Contestable Fund (New Zealand)*
  • Mediterranean diet and exercise to reduce cognitive decline and dementia risks in independently living older Australians: the MedWalk randomised controlled trial (2019-2023)
    National Health and Medical Research Council*

  • Mediterranean diet and exercise effects on gut microbiota: MedWalk Microbiome (2020-2022)
    Nutricia Research Foundation (Netherlands)*   

  • Complex Milk Lipids in older adults with Subjective Memory Complaints (2019-2021)
    Fonterra (New Zealand)/CSIRO

  • The effects of a vitamin, mineral and amino acid supplement on hangover symptom severity (2019-2020)
    BioRevive* 

  • Post prandial cognitive and vascular effects of DHA-rich Omega-3 powder (2019-2020)
    Nu-Mega Ingredients* 

  • A feasibility study to determine whether Australian children aged 8-12 years will eat almonds for 8 weeks and the impact on cognitive performance (2018-2019)
    Australian Almond Board*

  • Effects of a probiotic on mental fatigue (2018-2019)
    DuPont (Finland)

  • Dietary patterns, inflammatory salivary biomarkers, stool characterization among healthy toddlers aged 15-36 months old in Australia (2017-2018)
    Nutricia-Danone (Netherlands)

  • Effects of 4 weeks supplementation with a multi-vitamin/mineral preparation on neurocognitive function: A randomised, double-blind, placebo controlled trial (2017-18)
    Bayer Healthcare (Switzerland)

  • Investigation of the Effects of Longvida curcumin on cognitive function, mood and biomarkers of Health (2016-2018)
    Verdure Sciences (US)

  • Does 12 weeks of eating unsalted raw almonds improve cognitive performance in adults? (2015-2017)
    Almond Board of California (US) *

  • A randomized, double-blind, placebo-controlled, parallel trial investigating the neurocognitive effects of a proprietary spearmint extract in healthy older adults (2015-2016)
    Kemin Nutrition and Health (US)

  • Acute dose-dependent effects of resveratrol consumption on cerebrovascular function in adults with type 2 diabetes mellitus (2014-2015) Dementia Collaborative Research Centres*

  • A randomized, double blind, placebo-controlled, crossover trial investigating the effects of 2 nutraceuticals combination formulas on mental fatigue, mood and neurocognitive performance in healthy adults (2014-2105)
    LifeVantage Corporation (US)*

  • Controlled trials in ‘at risk’ humans to establish the cognitive benefits of a nutrient mixture and underlying mechanisms of action: the Cognitive Aging, Nutrition and Neurogenesis (C.A.N.N.) trial (2013-2018)
    Abbott Nutrition Grand Challenge grant (US) 

  • Brain oscillatory correlates of virtual spatial navigation across adulthood (2014-2015)
    Barbara Dicker Foundation*

  • Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT (2014-2016)
    NHMRC*

  • Assessment of anti-stress, behavioural, and neurophysiological effects of NeuroBliss®: A randomised, double-blind, placebo-controlled, crossover trial (2013-2014)
    Neurobrands (US)

  • A double-blind placebo-controlled trial of a Lactium™ and Zizyphus complex for sleep (2014-2016)
    Sanofi

  • The Neurocognitive effects of Lacprodan® PL-20 in elderly participants with age-associated memory impairment (2013-2017)
    Arla Foods (Denmark)

  • Glucose facilitation of cognitive function: effects of effort, age and glucose control (2010-2013)
    Australian Research Council Discovery Program

  • Improving cognitive function in the elderly (2010-2013)
    Australian Research Council Discovery Program*

  • Kava in the treatment of Generalised Anxiety Disorder: A 10-week randomized, double-blind, placebo-controlled study (2010-2014)
    NHMRC Fellowship*

  • Chronic effects of multi-vitamin/mineral preparations on brain imaging assessed with Steady State Topography and fMRI during periods of mental effort (2012-2014)
    Bayer Healthcare (Switzerland)

  • An investigation into the cognitive effects and bioavailability of components of green tea (2012-2013)
    GlaxoSmithKline (UK)

  • Investigation into the Acute and Chronic Effects of Longvida Curcumin on Inflammation, Cognitive Function and Mood in an elderly population (2012-2014)
    Verdure Sciences (US)
  • Neuroimaging changes underpinning improvements in cognition in the elderly 2011-2012)
    Australian Research Council Linkage Program * 

  • An investigation into the effects of glucose & caffeine on multitasking, mood and fMRI regional activation (2012-2013) GlaxoSmithKline (UK)  

  • An investigation into the effects of glucose alone and caffeine and glucose in combination on cognitive performance, fatigue and mood associated with  extended multi-tasking (2010-2011)
    GlaxoSmithKline (UK)
                                                              
  • Acute effects of multi-vitamin/mineral preparations on brain imaging assessed with Steady State Topography and fMRI during periods of mental effort (2010-2011)
    Bayer Healthcare (Switzerland)
  • Effect of resveratrol in red wine on cognitive function in older adults (2010-2011)
    Australian Wine Research Institute
  • Cognitive and mood effects of saccharides in middle-aged adults (2010-2011)
    Mannatech (US)*
  • The Effect of Exercise Programs on Cognitive Function (2010-2011)
    Personal Training Academy*

  • The acute effects of Panax quinquefolius on brain activity, mood and neurocognitive function in a healthy older population (2010-2011)
    Naturex (France)

  • Is augmented nitric oxide a mechanism for neurocognitive performance and cardiovascular health benefits of chewing gum? (2010-2011)
    Wrigley Science Institute (US)

  • Various confidential (2009-2011)
    Nestlé Research Centre (Switzerland). 

  • Factors affecting glucose enhancement of cognitive performance (2006-2009)
    Biotechnology and Biological Sciences Research Council (UK) 

  • Exploring the nutrition-behaviour axis (2007-2009)
    British Psychological Society Research Seminars Competition, UK* 

  • The role of glucoregulatory processes in the cognition-enhancing effects of selected botanicals (2008-2011)
    Naturex (France) 

  • Assessing anti-stress effects of lemon balm-containing foods (2008-2009)
    Cognis, (Germany) 

  • A study of the acute and chronic cognitive, neurocognitive and blood flow effects of polyphenols in middle aged volunteers (2008-2009)
    Barry Callebaut (Belgium)* 

  • Evaluation of ZE117 (HP) in smoking cessation (2008-2009)
    Flordis/Zeller (Switzerland)* 

  • Factors influencing mood and cognitive effects of chewing gum (2008-2011)   
    Wrigley Science institute (US) 

  • National Institute of Complementary Medicine Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease (2008-2010)
    NICM/NHMRC  

  • Polyunsaturated fats and cognitive function (2006-2009)
    Pharmaton SA (Switzerland)* 

  • The impact of glucoregulation and glucose on memory function (2006-2009)   
    Northumbria University (UK) 

  • An evaluation of the cognitive effects of glucose and malt extract in children'2007-2008
    Nestlé Research Centre (Switzerland) 

  • Cognitive and mood effects of Pharmaton platinum in healthy young participants (2007-2008)
    Pharmaton SA*  (Switzerland) 

  • Accommodation and development of Brain, Behaviour and Nutrition Research Centre (2006-2008)
    Department of Trade and Industry Science Research Investment Fund (SRIF) (UK) 

  • Dietary factors affecting children’s behaviour and cognition (2005-2008)
    Northumbria University*

  • Neurocognitive effects of cocoa polyphenols (2006-2007)
    Masterfoods (UK)
  • Effects of a multivitamin/guaraná supplement during cognitive demand (2006-2007)
    Bayer Healthcare (Switzerland)  
  • Anti-stress effects of chewing gum (2006-2007)
    Wrigley Science Institute (US)
  • Effects of DHA supplementation on mood and cognitive performance in children (2006-2007)
    Martek (US)
  • Effects of chronic ginkgo biloba/multivitamin supplementation on age-associated memory impairment (2005-2007)
    Bayer Healthcare (Switzerland)
  • Sabbatical Professorship (2006)
    Nestlé Research Centre (Switzerland) 
  • Neurocognitive and gluco-regulatory effects of Panax ginseng (2003-2006)
    Boehringer/Pharmaton SA (Switzerland)
  • The acute biobehavioural effects of caffeine in isolation and in combination with other naturally occuring concommitant phytonutrients (2003-2006)
    Cognitive Drug Research
  • Effects of conjugation of Ginkgo biloba with phosphatidylserine on cognitive performance (2003-2006)
    Boehringer/Pharmaton SA/Indena (Switzerland)
  • Neurocognitive effects of vitamin supplementation in children (2005-2006)
    Boehringer/Pharmaton SA* (Switzerland)
  • Anxiolytic assessment of a Valerian/Melissa combination (2003-2006)
    MedicHerb UK Ltd
  • Biobehavioural assessment of guaraná and guaraná-containing products (2004-2005)
    Boehringer/Pharmaton (Switzerland)
  • Neurocognitive effects of S. officinalis and M. officinalis (2004-2005)
    LichtwerPharma Co (Germany)

  • RESCUE: Effects of cueing in Parkinson’s disease (2001-2004)
    European Union Framework 5* 

  • Anxiolytic assessment of a Valerian/Melissa combination (2003)
    MedicHerb Ltd (UK)
       
  • Psychopharmacology of herbal supplements (1999-2002)
    Boehringer/Pharmaton SA (Switzerland)

  • Neurocognitive assessment in Chronic Fatigue Syndrome (1999-2002)
    Cognitive Drug Research (UK)

  • Psychopharmacology of oxygen administration (1996-1999)
    (Northumbria University)

[* = not principal Investigator]


Back to top

Professor Andrew Scholey
Monash and Swinburne Universities 
Melbourne

Australia
Email: andrew@scholeylab.com (or click icon bottom right)












My Google Scholar profile Follow me on Twitter My LinkedIn page My Academia profile My ORCID profile Email me
Download my CV here